Greg Bosch, MBA

Greg Bosch is the CEO of Geistlich Pharma North America, based in Princeton, NJ. As CEO, he has established Geistlich as the market leader in biomaterials/regenerative medicine in dentistry and also heads up Geistlich’s oncology program. Prior to Geistlich, he led PuriCore for 8 years taking them from a private venture-backed operation through a successful IPO. Greg began his career at American Hospital Supply/Baxter International where he held leadership roles of increasing responsibility over 19 years, including General Manager of the BioSurgery business which he grew to a $225 million business in 5 years.
Greg is an experienced CEO in the Life Sciences. He has global leadership experience in sales, marketing, R&D, operations, and mergers and acquisitions. Greg earned a degree in Public Policy from Duke University and an MBA focused in Finance from DePaul University’s Kellstadt Graduate School of Business.